Dextran Liposome (Dexsome™) Formulation
Dexsome is a patented solution containing dextran, liposomes and nutrients. LMI-Vet, LLC has developed the Dexsome technology for various applications in veterinary medicine, covered under US Patent No 7,220,538: “Composition for Maintaining Organ and Cell Viability”, with patent protection in 24 countries.
LMI-Vet, LLC will continue to strengthen its patent portfolio by working with Corporate Partners and Universities. In addition to patent protection, LMI-Vet, LLC has established internal know-how and trade secrets surrounding the Dexsome platform and Dexsome Intravenous Fluid technology.